Aethon Therapeutics, Inc.

Biotechnology company · New York, United States

Aethon Therapeutics, Inc. is a biotechnology company headquartered in New York, United States. Its earliest recorded incorporation is in 2022. It has reported private securities offerings to the US SEC, most recently $6 million sold in a notice filed in 2022.

Profile compiled from public records. Is this your company? Request a correction or update

Aethon Therapeutics at a glance

Typebiotechnology company
HeadquartersNew York, United States
Earliest incorporation on record2022
SEC CIK1958956

What does Aethon Therapeutics do?

Private fundraising reported to the SEC

1 Form D notice; the most recent reported $6 million sold (2022).

Frequently asked questions about Aethon Therapeutics

Where is Aethon Therapeutics headquartered?

Aethon Therapeutics, Inc. is headquartered in New York, United States.

What does Aethon Therapeutics do?

Aethon Therapeutics, Inc. is a biotechnology company.

When was Aethon Therapeutics founded?

The earliest incorporation on record for Aethon Therapeutics, Inc. is in 2022, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences